the Predictors of Hemorrhagic Transformation Subtypes in Acute Embolic Stroke Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 716 participants.
Also called NCT06653946
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 716 participants
- Sponsor
- Registry
-
NCT06653946
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Egypt
- Registry status
- Unknown status
Technical summary
Registry record NCT06653946. Non-randomized; no masking; primary purpose treatment. Start 2022-07-01 (actual); primary completion 2024-07-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- the Predictors of Hemorrhagic Transformation Subtypes in Acute Embolic Stroke Patients
- Condition
- Ischemic Stroke
- Condition
- Alteplase Adverse Reaction
- Intervention (Drug)
- Alteplase
- Intervention (Drug)
- Alteplase
- Lead sponsor
- Kafrelsheikh University
Record details
- Record id
cardio:ct-nct06653946- Content hash
280f9c191b2606344ba9e3c42a96b39f44cf9a8f6e7d57f2f807bbbce19fbb54